Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Investigating the impact of fluid removal speed on heart strain during dialysis

Official title: The Effect of Hemodialysis on proBNP

Run by Umeå University · NCT06153888 · Data updated 2026-11-12

This study tests if changing how quickly fluid is removed during dialysis can help reduce heart strain in adults who have gained weight between treatments.

More Dialysis trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorUmeå University
Academic / other
Locations1 site (Umeå)
StatusRecruiting
StartedMarch 20, 2023
Main results expectedMarch 30, 2026
Study endsApril 30, 2026
Registry record updatedDecember 16, 2024
Trial IDNCT06153888 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adult hemodialysis patients with significant inter-dialytic weight gain of 2.5% or more of their target weight.

Probably not a fit

Patients with active systemic inflammatory conditions or uncontrolled hyperphosphatemia may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study examines how the rate of fluid removal during chronic hemodialysis affects the release of cardiac markers, specifically NT-proBNP, which is associated with heart strain. By analyzing patients who experience significant inter-dialytic weight gain, the research aims to determine if adjusting the ultrafiltration rate could improve cardiovascular outcomes. The findings may lead to updated guidelines for dialysis prescriptions to better manage fluid overload and reduce cardiac risks in patients. The study involves adult patients undergoing hemodialysis and focuses on their physiological responses during treatment.

Why it matters

Potential benefit: If successful, this study could lead to improved dialysis prescriptions that reduce cardiovascular risks for patients with fluid overload.

How similar studies have gone: While there is ongoing research in this area, the specific approach of correlating ultrafiltration rates with cardiac strain markers is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult HD patients with an intra-dialytic weight gain (IDWG) ≥2.5% of target weight over the long interval (3 days) prior to inclusion.
* Patients need to be able to understand the study information
* Patients need to be able to give consent.

Exclusion Criteria:

* Active systemic inflammatory state such as extensive malignancy or acute septic infection.
* Uncontrolled hyperphosphatemia decided by the local routine of the physician (due to somewhat decreased efficacy of the low flux filter to eliminate phosphate)

Where it's running

  • Region Vasterbotten, Norrlands Universitetssjukhus, Dialysen
    Umeå, Sweden
    Recruiting

Study contacts

  • Principal investigator: Bernd Stegmayr, MD, PhD — Umea University, Umea, Sweden
  • Study coordinator: Bernd Stegmayr, MD, PhD
  • Email: bernd.stegmayr@umu.se
  • Phone: +46706264533

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.